The day after the 2014 Breakthrough Prize in Life Sciences winners are announced, the recipients – along with 2013 recipients, UCSF Nobel laureates and other luminaries in the field – will participate in a symposium on the state of research in cancer, genetics, neurobiology and stem cells.
December 10, 2013
November 21, 2013
A UCSF investigator has won an eight-year grant from the National Cancer Institute for a major investigation into anal cancer, a debilitating and sometimes fatal disease largely concentrated among people with HIV.
November 20, 2013
The protein in cells that most often drives the development of cancers has eluded scientists’ efforts to block it for three decades — until now.
November 15, 2013
Precision Medicine Pillar No. 2: Basic Discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process.
October 16, 2013
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
October 11, 2013
The way cells divide to form new cells – to support growth, to repair damaged tissues, or simply to maintain our healthy adult functioning – is controlled in previously unsuspected ways, UCSF researchers have discovered.
September 19, 2013
UCSF will receive a five year, $20 million grant as part of a first-of-its-kind tobacco science regulatory program by the U.S. Food and Drug Administration and the National Institutes of Health.
August 26, 2013
A team led by UCSF researchers has called for simplified guidelines on when to biopsy thyroid nodules for cancer, which they say would result in fewer unnecessary biopsies.
August 19, 2013
A natural form of sugar could offer a noninvasive way to precisely image tumors and determine whether cancer medication is effective using new technology developed at UCSF in collaboration with GE Healthcare.
July 29, 2013
A group of scientists convened by the National Cancer Institute and chaired by a UCSF breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”